On Saturday, December 4, 2021, starting at 10:00 p.m. EST we will be launching the New FAST Graphs. This may cause temporary interruptions. We are sorry for any inconvenience this may cause.

CVS Health (CVS)

CVS Health Corp. (CVS): Fast Fundamental Analysis | FAST Graphs

2021-11-04

Research Articles

Introduction According to Zacks Investment Research CVS Health is the world’s 7th largest company by revenue and ranked 7th on the Fortune Global 500 list. The company reported Q3 earnings on November 2, 2021 and reported Non-GAAP EPS of $1.97 beats by $0.18; GAAP EPS of $1.20 misses by $0.20. Revenue of $73.79B (+10.0% Y/Y) […]

Building A Dividend Growth Portfolio from Scratch in Today’s Expensive Market

2021-03-17

Research Articles

Introduction Building A Dividend Growth Portfolio Before we talk about a dividend growth portfolio, the stock market as measured by the S&P 500 is at an all-time high. However, that is not what concerns me. What I am worried about is the extremely high relative valuation of the market. To be clear, the market can […]

Is the Death of Retail Trade Greatly Exaggerated? Part 16

2019-04-17

Research Articles

Introduction Simply Google the phrase “what effect is Amazon having on retail” and you’ll discover a significant amount of information, articles and theories.  Personally, I found the following article written by Susan Ward that articulated the sales of brick-and-mortar versus online to be quite illuminating.  Her opening paragraph mirrors the title of this article as […]

The S&P 500 is Overvalued These 10 Dividend Growth Stocks Are Not: Part 3

2018-04-13

Research Articles

Introduction This is the third of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value.  With this article I will be covering 10 additional dividend growth research candidates with moderate to higher yields in addition to the initial 20 that I presented in part 1 found here and […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.